Inducing the elimination of human pancreatic carcinoma (CFPAC-1) and glioblastoma (U87-MG) cell line in combination therapy with MSC-TRAIL in vitro (Coccè et al., 2020). This evidence concerns the gene TNFSF10 and glioblastoma.